Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126974431 | 12697443 | 1 | I | 20160526 | 20160830 | 20160830 | PER | US-PFIZER INC-2016278462 | PFIZER | 73.00 | YR | F | Y | 80.29000 | KG | 20160830 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126974431 | 12697443 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 1X/DAY (FOR TWO DAYS) | Y | N18481 | 21446 | 50 | MG | CAPSULE, HARD | QD | ||||
126974431 | 12697443 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 2X/DAY | Y | 21446 | 50 | MG | CAPSULE, HARD | BID | |||||
126974431 | 12697443 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | UNK | Y | 20235 | ||||||||||
126974431 | 12697443 | 4 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 5 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 6 | C | VIT B COMPLEX | 2 | UNK | 0 | ||||||||||||
126974431 | 12697443 | 7 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 8 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 9 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 10 | C | DOCUSATE CALCIUM. | DOCUSATE CALCIUM | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 11 | C | LEVAQUIN | LEVOFLOXACIN | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 12 | C | ATIVAN | LORAZEPAM | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 13 | C | MESALAMINE. | MESALAMINE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 14 | C | MOMETASONE | MOMETASONE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 15 | C | GRAPE SEED EXTRACT | GRAPE SEED EXTRACT | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 16 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 17 | C | K-DUR | POTASSIUM CHLORIDE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 18 | C | XIFAXAN | RIFAXIMIN | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 19 | C | REVATIO | SILDENAFIL CITRATE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 20 | C | DEMADEX | TORSEMIDE | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 21 | C | TRAMADOL. | TRAMADOL | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 22 | C | WARFARIN | WARFARIN | 1 | UNK | 0 | |||||||||||
126974431 | 12697443 | 23 | C | OPSUMIT | MACITENTAN | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126974431 | 12697443 | 1 | Neuropathy peripheral |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126974431 | 12697443 | Bronchitis | |
126974431 | 12697443 | Condition aggravated | |
126974431 | 12697443 | Confusional state | |
126974431 | 12697443 | Depression | |
126974431 | 12697443 | Dizziness | |
126974431 | 12697443 | Dyspnoea | |
126974431 | 12697443 | Fall | |
126974431 | 12697443 | Feeling abnormal | |
126974431 | 12697443 | Gait disturbance | |
126974431 | 12697443 | Intentional product use issue | |
126974431 | 12697443 | Memory impairment | |
126974431 | 12697443 | Pain in extremity | |
126974431 | 12697443 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126974431 | 12697443 | 2 | 20160523 | 0 |